Healthcare Equipment and Supplies
Company Overview of Calhoun Vision, Inc.
Calhoun Vision, Inc. provides light adjustable lenses for use in cataract surgery. It offers its products to patients in Germany, the United Kingdom, France, Italy, Spain, Mexico, the Czech Republic, and Canada. The company was founded in 1997 and is based in Pasadena, California.
171 North Altadena Drive
Pasadena, CA 91107
Founded in 1997
Key Executives for Calhoun Vision, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2015.
Calhoun Vision, Inc. Key Developments
Calhoun Vision, Inc. Announces Executive Appointments
Jun 18 15
Calhoun Vision, Inc. announced the appointments of Ron Kurtz, M.D. and Eric Weinberg to the positions of Chief Operations Officer and Chief Commercial Officer, respectively. Dr. Kurtz most recently co-founded LenSx Lasers and served as the company's President and Chief Executive Officer until its August 2010 acquisition by Alcon Inc. when he became General Manager of Alcon LenSx. Eric Weinberg was also a co-founder of LenSx Lasers, and served as its Chief Commercial Officer until the acquisition of LenSx by Alcon.
Calhoun Vision, Inc. Names Rick A. Heinick as Chief Executive Officer and President, Effective March 30, 2015
Mar 19 15
Calhoun Vision, Inc. announced that Rick A. Heinick has been named Chief Executive Officer and President, effective March 30. Prior to Calhoun, he served as Executive Vice President and Chief Human Resources and Transformation Officer at Bausch + Lomb Incorporated. Most recently, Mr. Heinick was Executive Vice President of AECOM. Mr. Heinick currently serves on the board of directors of Amydis Diagnostics, and has served on the boards of the Association of the Blind and Visually Impaired and the Rochester Business Alliance.
Calhoun Vision Announces Enrollment of the 300(th) Patient in the Phase III Clinical Study of its Light Adjustable Lens
Jun 25 14
Calhoun Vision announced enrollment of the 300(th) patient in the Phase III clinical study of its Light Adjustable Lens (LAL(R)). The study, which is being conducted at 18 centers across the country, will include a total of 600 patients, with 400 implanted with the LAL and 200 implanted with a monofocal control lens of the surgeon's choosing. Unlike traditional intraocular lenses, which are made of non-adjustable material, the LAL technology is designed to allow surgeons for the first time to change and customize the power of the lens after it has been implanted in the eye. The LAL is implanted in the same way as with standard cataract surgery, but because it is adjusted after implantation, the lens' performance is not affected by variables such as wound healing and changes in lens position. The patient returns for one or two follow-up visits, during which the surgeon evaluates his or her vision and performs an adjustment to customize the lens to the individual patient. This is accomplished by exposing the lens to UV-light from a special light delivery device, which changes the shape and power of the lens. Once the desired visual target is achieved, the surgeon locks in the lens with a final light treatment to prevent any further power change.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 4, 2015